Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.58 | N/A | +14.30% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.58 | N/A | +14.30% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management remains cautiously optimistic about the company's direction. They highlighted the importance of maintaining profitability.
Management expressed satisfaction with the EPS performance despite not providing revenue details.
They emphasized ongoing efforts to improve operational efficiency.
Agilent Technologies reported a better-than-expected EPS, which indicates strong profitability. However, the stock experienced a slight decline of 0.09%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of revenue figures and future guidance could lead to uncertainty among investors.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BOOZ ALLEN HAMILTON Class A
May 22, 2017